Biomarin Pharmaceutical Inc. (BMRN)
Market Closed
17 Jul, 20:00
$
59. 59
-0.41
-0.6833%
$
11.43B Market Cap
126.18 P/E Ratio
- Div Yield
1.61M Volume
1 Eps
$ 60
Previous Close 
Want to track BMRN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Biomarin Pharmaceutical Inc. (BMRN) Statistics
Valuation metrics
Market Cap 11.43B
Enterprise value 10.73B
Trailing P/E (ttm) 42.56
Forward P/E 8.4
PEG ratio -0.86
Price/Sales (ttm) 3.55
Price/Book (mrq) 1.85
Enterprise Value/Revenue 3.31
Enterprise Value/EBITDA 22.25
Overview
Shares outstanding 193.27M
Float 192.17M
Shares short 10.79M
% Held by insiders 0%
% Held by institutions 1.03%
Average volume (10 days) 1.43M
Average volume (90 days) 2.07M
Price summary
52-Week low 49.26
52-Week high 66.28
Beta 0.23
50-Day moving average 57.01
200-Day moving average 56.67
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.08%
Operating margin 0.14%
Operational effectiveness
Return on assets 0.03%
Return on equity 0.04%
Income Statement
Revenue (ttm) 3.24B
Revenue per share (ttm) 16.84
Quarterly revenue growth (yoy) 0.03%
Gross profit (ttm) 1.66B
EBITDA 572.94M
Net income to common (ttm) 268.74M
Diluted EPS (ttm) 1.4
Quarterly earnings growth (yoy) -0.43%
Balance Sheet
Total cash (mrq) 2.22B
Total cash per share (mrq) 11.55
Total debt (mrq) 1.44B
Total Debt/Equity (mrq) 0.23
Current ratio (mrq) 5.81%
Book value per share (mrq) 32.27
Cash Flow
Cash flow statement 874.25M
Levered free cash flow (LFCF) 459.42M
